Screening of antinuclear antibodies: comparison between enzyme immunoassay based on nuclear homogenates, purified or recombinant antigens and immunofluorescence assay
- 1 January 2004
- journal article
- research article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 42 (10), 1155-1160
- https://doi.org/10.1515/cclm.2004.235
Abstract
Current clinical practice considers antinuclear antibody (ANA) testing as a screening test; this has a major impact on laboratory work with a growing volume of analyses that need to be performed rapidly, to maintain good specificity and sensitivity. Ongoing discussions have been raised in order to identify the best technology to use in ANA screening, taking into account both clinical and economical implications. The aim of our study was to compare three different enzyme immunoassays (EIA) with immunofluorescence (IF) assay in order to identify which test is better for use as a screening test. The study was performed on 473 sera and the three different EIA tests were based on nuclear homogenates from HeLa cells, purified antigens from HEp-2 cells and recombinant antigens, respectively. The concordance between EIA-ANA and IF-ANA techniques, determined by the κ statistic, was acceptable, but not complete, and discrepancies between both EIA-positive/IF-negative samples and IF-positive/EIA-negative were found. Both methods show interesting diagnostic abilities, however, the IF-ANA assay seems to be the first choice test in a well-standardized immunofluorescence laboratory with experienced microscopists, whereas the EIA test might be useful especially in large-scale ANA screening.Keywords
This publication has 11 references indexed in Scilit:
- Antinuclear antibodies (ANA) screening by enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: analytical and clinical evaluationClinical Biochemistry, 2002
- Antinuclear antibody screening in this new millennium: farewell to the microscope?Scandinavian Journal of Rheumatology, 2001
- Guidelines for Clinical Use of the Antinuclear Antibody Test and Tests for Specific Autoantibodies to Nuclear AntigensArchives of Pathology & Laboratory Medicine, 2000
- Screening Tests for Antinuclear Antibodies (ANA): Selective Use of Central Nuclear Antigens as a Rational Basis for Screening by ELISAJournal of Autoimmunity, 1999
- A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities: I. Precision, sensitivity, and specificityArthritis & Rheumatism, 1999
- A Review of Methods Available for the Identification of Both Organ-Specific and Non-Organ-Specific AutoantibodiesAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1998
- Clinical significance of antinuclear antibodies. Comparison of detection with immunofluorescence and enzyme‐linked immunosorbent assaysArthritis & Rheumatism, 1997
- Range of antinuclear antibodies in “healthy” individualsArthritis & Rheumatism, 1997
- Antinuclear antibody determination in a routine laboratory.Annals Of The Rheumatic Diseases, 1996
- Screening for Antinuclear Antibodies by Enzyme ImmunoassayAmerican Journal of Clinical Pathology, 1996